A Gantt chart that shows the different project phases for internal programs and partnered programs. For internal programs it shows that Synavive (RA/OA) is at Phase II Z160 (Pain) is at Phase I and Ion Channel Candidates has completed the preclinical phase but has not started Phase I. For partnered programs it shows that Exalgo (Covidien/Mallinckrodt Pain) is at market that Prednisporin (Sanofi Ophthalmic) is in Phase II and that Novartis (Oncology) is in discovery.
Description
Type
Category
-
Date
2008
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.